Short and Long-Acting Monoclonal Antibodies for RSV Immunoprophylaxis

CAN-eng

$0

gratuit

Mainpro+

1 heure

Infectious Disease, Respirology

1.0 Credits

This course is expired! Browse All Courses
APPRENDRE ENCORE PLUS

Description du cours

This is a 60-minute CFPC Mainpro+ certified eCME program for Canadian HCPs. The goal is to provide education on the burden of respiratory syncytial virus (RSV) and guidance on RSV prevention and control measures. This program is designed to provide practical information on the monoclonal antibodies authorized for RSV prophylaxis in Canada, including a new long-acting monoclonal antibody for all infants. 

This program has received an unrestricted educational grant or in-kind support from Sanofi.

Détails du cours

Date d'expiration : 2024-09-28

Métiers: Médecin

Faculté

Cora Constantinescu, MD, FRPCPC

Vivien Brown, MDCM, CCFP, FCFP, NCMP

Christine Palmay, MD, CCFP 

Sofia Nastis, MD, CCFP

Accréditation

This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 1.0 Mainpro+ Credit.

Cert+ Program ID#: 200723

Objectif(s) d'apprentissage

Upon completion of this continuing education, program participants will be better able to:

  • Reconnaître the prevalence and burden of RSV disease in all infants
  • Explain the role of monoclonal antibodies for protection against preventable disease
  • Apply approved RSV immunoprophylaxis in clinical practice
  • Employ strategies to discuss RSV immunoprophylaxis for all infants and children
This course is expired! Browse All Courses